Latest news
Loading news…
Inhibikase Therapeutics is a developer of cellular Abelson tyrosine kinase inhibitors to treat infections and other diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
10
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Atlanta, Georgia, United States
Key People at Inhibikase Therapeutics
Chief Executive Officer
Chief Financial Officer
Chief Commercial and Strategy Officer
10
professional contacts at Inhibikase Therapeutics
Contact execs at Inhibikase Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Inhibikase Therapeutics
Loading news…
FAQs about Inhibikase Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.